Angiotensin converting enzyme inhibition prevents development of collapsing focal segmental glomerulosclerosis in Thy-1.1 transgenic mice

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3087-3097

  Smeets, Bart ^a   Steenbergen, Mark L M ^a   Dijkman, Henry B P M ^a   Verrijp, Kiek N ^a   te Loeke, Nathalie A J M ^a   Aten, Jan ^b   Steenbergen, Eric J ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiotensin converting enzyme; Collapsing glomerulopathy; Connective tissue growth factor; Focal segmental glomerulosclerosis; Parietal epithelial cell; Podocyte

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CONNECTIVE TISSUE GROWTH FACTOR; DESMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; MONOCLONAL ANTIBODY;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; TRANSGENIC MOUSE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, THY-1; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; MICE; MICE, TRANSGENIC; PEPTIDYL-DIPEPTIDASE A;

EID: 33749986028     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl495     Document Type: Article

References (20)

1. Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int 1996; 57 [Suppl]: S119-S131
2. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992; 20: 240-248
3. Jafar TH, Stark PC, Schmid CH et al. Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252
4. Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997; 52: 1497-1510
5. Smeets B, Te Loeke NA, Dijkman HB et al. The parietal epithelial cell: A key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 2004; 15: 928-939
6. Smeets B, Dijkman HB, Te Loeke NA et al. Podocyte changes upon induction of albuminuria in Thy-1.1 transgenic mice. Nephrol Dial Transplant 2003; 18: 2524-2533
7. Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T. Permanent genetic tagging of podocytes: Fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005; 16: 2257-2262
8. Zhong J, Zuo Y, Ma J et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68: 1048-1060
9. Dijkman H, Smeets B, van der LJ, Steenbergen E, Wetzels J. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int 2005; 68: 1562-1572
10. Dijkman HB, Weening JJ, Smeets B et al. Proliferating cells in HIV and pamidronate associated collapsing FSGS are parietal epithelial cells. Kidney Int 2006; 10: 338-344
11. Kollias G, Evans DJ, Ritter M, Beech J, Morris R, Grosveld F. Ectopic expression of Thy-1 in the kidneys of transgenic mice induces functional and proliferative abnormalities. Cell 1987; 51: 21-31
12. Ramaekers FC, Moesker O, Huysmans A et al. Intermediate filament proteins in the study of tumor heterogeneity: An in-depth study of tumors of the urinary and respiratory tracts. Ann N Y Acad Sci 1985; 455: 614-634
13. Mentzel S, van Son JP, De Jong AS et al. Mouse glomerular epithelial cells in culture with features of podocytes in vivo express aminopeptidase A and angiotensinogen but not other components of the renin-angiotensin system. J Am Soc Nephrol 1997; 8: 706-719
14. Kanemoto K, Usui J, Tomari S et al. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest 2003; 83: 1615-1625
15. Barisoni L, Madaio MP, Eraso M, Gasser DL, Nelson PJ. The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 2005; 16: 2847-2851
16. Patek CE, Fleming S, Miles CG et al. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Hum Mol Genet 2003; 12: 2379-2394
17. Ruperez M, Ruiz-Ortega M, Esteban V et al. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 2003; 163: 1937-1947
18. Kanemoto K, Usui J, Nitta K et al. In situ expression of connective tissue growth factor in human crescentic glomerulonephritis. Virchows Arch 2004; 444: 257-263
19. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36: 626-635
20. Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 2003; 64: 1462-1471